KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.24 $2.30 Thursday, 25th Apr 2024 ATOS stock ended at $1.52. This is 1.33% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 8.28% from a day low at $1.45 to a day high of $1.57.
90 days $0.80 $2.30
52 weeks $0.590 $2.30

Historical Atossa Genetics Inc. prices

Date Open High Low Close Volume
Jan 08, 2024 $0.91 $0.97 $0.91 $0.95 458 720
Jan 05, 2024 $0.91 $0.95 $0.88 $0.93 515 774
Jan 04, 2024 $0.96 $0.96 $0.91 $0.91 324 575
Jan 03, 2024 $0.92 $0.96 $0.90 $0.93 307 263
Jan 02, 2024 $0.90 $0.99 $0.90 $0.94 935 687
Dec 29, 2023 $1.05 $1.05 $0.87 $0.88 1 572 218
Dec 28, 2023 $0.95 $1.10 $0.95 $0.98 2 595 313
Dec 27, 2023 $0.83 $0.91 $0.83 $0.90 785 506
Dec 26, 2023 $0.770 $0.85 $0.770 $0.84 742 420
Dec 22, 2023 $0.730 $0.798 $0.730 $0.780 517 724
Dec 21, 2023 $0.721 $0.739 $0.720 $0.735 246 137
Dec 20, 2023 $0.729 $0.730 $0.710 $0.728 243 638
Dec 19, 2023 $0.730 $0.730 $0.702 $0.719 278 085
Dec 18, 2023 $0.722 $0.740 $0.720 $0.720 212 927
Dec 15, 2023 $0.740 $0.749 $0.721 $0.741 197 793
Dec 14, 2023 $0.760 $0.760 $0.720 $0.730 276 697
Dec 13, 2023 $0.700 $0.747 $0.700 $0.737 241 471
Dec 12, 2023 $0.740 $0.740 $0.700 $0.700 206 998
Dec 11, 2023 $0.755 $0.769 $0.730 $0.731 167 895
Dec 08, 2023 $0.740 $0.767 $0.720 $0.753 190 488
Dec 07, 2023 $0.750 $0.755 $0.729 $0.736 173 069
Dec 06, 2023 $0.769 $0.770 $0.727 $0.735 186 246
Dec 05, 2023 $0.730 $0.762 $0.710 $0.756 247 721
Dec 04, 2023 $0.759 $0.768 $0.710 $0.735 413 819
Dec 01, 2023 $0.734 $0.770 $0.720 $0.760 242 979
Click to get the best stock tips daily for free!

About Atossa Genetics Inc.

Atossa Genetics Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien... ATOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT